8-K Announcements
6Apr 29, 2026·SEC
Feb 12, 2026·SEC
Jan 5, 2026·SEC
Sabra Health Care REIT, Inc. (SBRA) fundamental analysis — strengths, weaknesses & financial health based on data analysis
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Sabra Health Care REIT, Inc. (SBRA) stock price & volume — 10-year historical chart
Sabra Health Care REIT, Inc. (SBRA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Sabra Health Care REIT, Inc. (SBRA) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 29, 2026 | $0.16vs $0.16-0.9% | $222Mvs $209M+6.0% |
| Q1 2026 | Feb 12, 2026 | $0.38vs $0.17+123.5% | $212Mvs $198M+7.0% |
| Q4 2025 | Nov 5, 2025 | $0.38vs $0.38+0.0% | $190Mvs $202M-5.9% |
| Q3 2025 | Aug 4, 2025 | $0.38vs $0.37+2.7% | $189Mvs $187M+0.9% |
Sabra Health Care REIT, Inc. (SBRA) competitors in Senior housing and skilled nursing — business model, growth, and fundamentals comparison
Sabra Health Care REIT, Inc. (SBRA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Sabra Health Care REIT, Inc. (SBRA) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 405.65M | 623.41M | 668.18M | 598.57M | 569.54M | 624.81M | 647.51M | 703.24M | 774.63M | 812.84M |
| Revenue Growth % | 55.7% | 53.68% | 7.18% | -10.42% | -4.85% | 9.7% | 3.63% | 8.61% | 10.15% | 12.89% |
| Property Operating Expenses | 17.86M | 49.55M | 109.71M | 131.55M | 141.2M | 162.61M | 195.25M | 227.09M | 271.11M | 296.81M |
| Net Operating Income (NOI) | 387.79M▲ 0% | 573.86M▲ 48.0% | 558.48M▼ 2.7% | 467.02M▼ 16.4% | 428.34M▼ 8.3% | 462.2M▲ 7.9% | 452.27M▼ 2.1% | 476.15M▲ 5.3% | 503.53M▲ 5.8% | 516.03M▲ 0% |
| NOI Margin % | 95.6% | 92.05% | 83.58% | 78.02% | 75.21% | 73.97% | 69.85% | 67.71% | 65% | 63.48% |
| Operating Expenses | 163.4M | 266.91M | 30.89M | 467.02M | 217.59M | 227.36M | 230.56M | 219.12M | 239.66M | 280.47M |
| G&A Expenses | 32.4M | 36.46M | 30.89M | 32.76M | 34.67M | 39.57M | 47.47M | 50.07M | 53.71M | 55.84M |
| EBITDA | 387.82M | 613.14M | 708.63M | 416.29M | 389.74M | 422.62M | 404.8M | 426.65M | 450.86M | 432.19M |
| EBITDA Margin % | 95.6% | 98.35% | 106.05% | 69.55% | 68.43% | 67.64% | 62.52% | 60.67% | 58.2% | 53.17% |
| Depreciation & Amortization | 163.43M | 306.19M | 181.04M | 176.74M | 178.99M | 187.78M | 183.09M | 169.62M | 187M | 196.63M |
| D&A / Revenue % | 40.29% | 49.11% | 27.09% | 29.53% | 31.43% | 30.05% | 28.28% | 24.12% | 24.14% | 24.19% |
| Operating Income | 224.39M▲ 0% | 306.95M▲ 36.8% | 527.59M▲ 71.9% | 0▼ 100.0% | 210.75M▲ 0% | 234.84M▲ 11.4% | 221.71M▼ 5.6% | 257.03M▲ 15.9% | 263.87M▲ 2.7% | 235.56M▲ 0% |
| Operating Margin % | 55.32% | 49.24% | 78.96% | 0% | 37% | 37.59% | 34.24% | 36.55% | 34.06% | 28.98% |
| Interest Expense | 88.44M | 147.11M | 126.61M | 100.42M | 98.63M | 105.47M | 112.96M | 115.27M | 112.49M | 4M |
| Interest Coverage | 2.80x | 2.92x | 2.73x | 2.39x | -0.13x | 0.28x | 1.14x | 2.11x | 2.40x | - |
| Non-Operating Income | -14.93M | -122.92M | 181.55M | -239.55M | 223.53M | 205.73M | 92.99M | 14.04M | -5.97M | -5.94M |
| Pretax Income | 159.02M▲ 0% | 282.13M▲ 77.4% | 72.42M▼ 74.3% | 139.13M▲ 92.1% | -111.41M▼ 180.1% | -76.36M▲ 31.5% | 15.76M▲ 120.6% | 127.72M▲ 710.5% | 157.35M▲ 23.2% | 156.06M▲ 0% |
| Pretax Margin % | 39.2% | 45.26% | 10.84% | 23.24% | -19.56% | -12.22% | 2.43% | 18.16% | 20.31% | 19.2% |
| Income Tax | 651K | 3.01M | 3.4M | 710K | 1.84M | 1.24M | 2M | 1M | 1.84M | 1.95M |
| Effective Tax Rate % | 0.41% | 1.07% | 4.7% | 0.51% | -1.66% | -1.63% | 12.7% | 0.79% | 1.17% | 1.25% |
| Net Income | 158.38M▲ 0% | 279.08M▲ 76.2% | 69M▼ 75.3% | 138.42M▲ 100.6% | -113.26M▼ 181.8% | -77.61M▲ 31.5% | 13.76M▲ 117.7% | 126.71M▲ 821.1% | 155.61M▲ 22.8% | 156.19M▲ 0% |
| Net Margin % | 39.04% | 44.77% | 10.33% | 23.12% | -19.89% | -12.42% | 2.12% | 18.02% | 20.09% | 19.21% |
| Net Income Growth % | 125.37% | 76.21% | -75.28% | 100.62% | -181.82% | 31.48% | 117.73% | 821.14% | 22.81% | 10.96% |
| Funds From Operations (FFO) | 321.81M▲ 0% | 585.27M▲ 81.9% | 250.04M▼ 57.3% | 315.15M▲ 26.0% | 65.73M▼ 79.1% | 110.18M▲ 67.6% | 196.84M▲ 78.7% | 296.33M▲ 50.5% | 342.61M▲ 15.6% | 352.82M▲ 0% |
| FFO Margin % | 79.33% | 93.88% | 37.42% | 52.65% | 11.54% | 17.63% | 30.4% | 42.14% | 44.23% | 43.41% |
| FFO Growth % | 97.15% | 81.87% | -57.28% | 26.04% | -79.14% | 67.61% | 78.66% | 50.54% | 15.61% | 64.73% |
| FFO per Share | 3.04 | 3.27 | 1.33 | 1.52 | 0.30 | 0.48 | 0.85 | 1.26 | 1.40 | 1.38 |
| FFO Payout Ratio % | 56.58% | 55.57% | 134.15% | 88.31% | 399.97% | 251.56% | 140.95% | 94.54% | 84.5% | 61.82% |
| EPS (Diluted) | 1.40▲ 0% | 1.56▲ 11.4% | 0.37▼ 76.3% | 0.67▲ 81.1% | -0.52▼ 177.6% | -0.34▲ 34.6% | 0.06▲ 117.4% | 0.54▲ 813.7% | 0.64▲ 18.5% | 0.61▲ 0% |
| EPS Growth % | 52.17% | 11.43% | -76.28% | 81.08% | -177.61% | 34.62% | 117.38% | 813.71% | 18.52% | 7.19% |
| EPS (Basic) | 1.40 | 1.57 | 0.37 | 0.67 | -0.52 | -0.34 | 0.06 | 0.54 | 0.64 | - |
| Diluted Shares Outstanding | 105.84M | 178.72M | 188.13M | 207.25M | 219.07M | 230.95M | 232.79M | 236.05M | 244.5M | 255.97M |
Sabra Health Care REIT, Inc. (SBRA) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 7.03B | 6.67B | 6.07B | 5.99B | 5.97B | 5.75B | 5.39B | 5.3B | 5.49B | 5.59B |
| Asset Growth % | 210.35% | -5.22% | -8.94% | -1.38% | -0.32% | -3.67% | -6.29% | -1.53% | 3.58% | 13.69% |
| Real Estate & Other Assets | 5.99B | 5.85B | 5.34B | 5.29B | 5.5B | 5.32B | 4.98B | 4.9B | 5.06B | 0 |
| PP&E (Net) | 5.99B | 5.85B | 9.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investment Securities | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 |
| Total Current Assets | 822.24M | 296.28M | 262.66M | 285.07M | 253.99M | 201.84M | 180.53M | 198.09M | 189.43M | 264.62M |
| Cash & Equivalents | 518.63M | 50.23M | 39.1M | 59.08M | 112M | 49.31M | 41.28M | 60.47M | 71.54M | 116.53M |
| Receivables | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 68.82M | 9.43M | 10.05M | 6.45M | 3.89M | 4.62M | 5.43M | 5.87M | 6.6M | 0 |
| Intangible Assets | 167.12M | 131.1M | 0 | 0 | 54.06M | 40.13M | 30.9M | 27.46M | 65.32M | 67.41M |
| Total Liabilities | 3.6B | 3.41B | 2.58B | 2.58B | 2.59B | 2.69B | 2.58B | 2.56B | 2.67B | 2.8B |
| Total Debt | 3.39B | 3.23B | 2.48B | 2.43B | 2.44B | 2.55B | 2.45B | 2.44B | 2.55B | 1.26B |
| Net Debt | 2.88B | 3.18B | 2.43B | 2.36B | 2.33B | 2.5B | 2.41B | 2.38B | 2.48B | 1.14B |
| Long-Term Debt | 3.39B | 3.23B | 2.4B | 2.35B | 2.39B | 2.31B | 2.32B | 2.31B | 2.31B | 0 |
| Short-Term Borrowings | 0 | 3.42M | 3.57M | 18.42M | 0 | 196.98M | 94.43M | 106.55M | 217.58M | 1.26B |
| Capital Lease Obligations | 98.02M | 83.73M | 79.75M | 57.73M | 49.71M | 42.24M | 32.53M | 26.85M | 21.38M | 67.76M |
| Total Current Liabilities | 102.52M | 94.83M | 0 | 0 | 142.99M | 339.24M | 231.41M | 224.45M | 336.91M | 1.26B |
| Accounts Payable | 102.52M | 94.83M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 3.6B | 3.41B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | -1.29B | -2.48B | -2.41B | 0 | 0 | 0 | 0 | 0 | 1.55B |
| Total Equity | 3.44B▲ 0% | 3.25B▼ 5.3% | 3.49B▲ 7.2% | 3.41B▼ 2.3% | 3.38B▼ 0.9% | 3.06B▼ 9.6% | 2.8B▼ 8.3% | 2.74B▼ 2.2% | 2.82B▲ 3.0% | 2.79B▲ 0% |
| Equity Growth % | 238.44% | -5.31% | 7.18% | -2.27% | -0.87% | -9.56% | -8.31% | -2.19% | 3.01% | 7.34% |
| Shareholders Equity | 3.43B | 3.25B | 3.49B | 3.41B | 3.38B | 3.06B | 2.8B | 2.74B | 2.82B | 2.79B |
| Minority Interest | 4.44M | 4.33M | 0 | 0 | 0 | 0 | 0 | 0 | 1.95M | 1.88M |
| Common Stock | 1.78M | 1.78M | 2.05M | 2.11M | 2.3M | 2.31M | 2.31M | 2.38M | 2.52M | 2.52M |
| Additional Paid-in Capital | 3.64B | 3.51B | 4.07B | 4.16B | 4.48B | 4.49B | 4.49B | 4.59B | 4.84B | 0 |
| Retained Earnings | -217.24M | -271.6M | -573.28M | -716.2M | -1.1B | -1.45B | -1.72B | -1.87B | -2.01B | 0 |
| Preferred Stock | 58K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Return on Assets (ROA) | 3.41% | 4.07% | 1.08% | 2.3% | -1.9% | -1.32% | 0.25% | 2.37% | 2.88% | 2.84% |
| Return on Equity (ROE) | 7.11% | 8.34% | 2.05% | 4.01% | -3.34% | -2.41% | 0.47% | 4.57% | 5.59% | 5.6% |
| Debt / Assets | 48.27% | 48.49% | 40.89% | 40.6% | 40.96% | 44.35% | 45.42% | 46.09% | 46.42% | 22.47% |
| Debt / Equity | 0.99x | 0.99x | 0.71x | 0.71x | 0.72x | 0.83x | 0.87x | 0.89x | 0.90x | 0.90x |
| Net Debt / EBITDA | 7.42x | 5.19x | 3.43x | 5.68x | 5.98x | 5.91x | 5.94x | 5.59x | 5.50x | 5.50x |
| Book Value per Share | 32.48 | 18.21 | 18.54 | 16.45 | 15.43 | 13.23 | 12.04 | 11.61 | 11.55 | 10.89 |
Sabra Health Care REIT, Inc. (SBRA) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 133.49M | 358.54M | 372.48M | 354.85M | 356.39M | 315.73M | 300.57M | 310.54M | 348.61M | 348.61M |
| Operating CF Growth % | -24.47% | 168.6% | 3.89% | -4.73% | 0.43% | -11.41% | -4.8% | 3.32% | 12.26% | 35.28% |
| Operating CF / Revenue % | 32.91% | 57.51% | 55.74% | 59.28% | 62.57% | 50.53% | 46.42% | 44.16% | 45% | 42.89% |
| Net Income | 158.37M | 279.12M | 69.02M | 138.42M | -113.26M | -77.61M | 13.76M | 126.71M | 155.51M | 156.19M |
| Depreciation & Amortization | 112.97M | 199.08M | 181.55M | 176.74M | 178.99M | 187.78M | 183.09M | 169.62M | 187M | 196.51M |
| Stock-Based Compensation | 8.36M | 7.65M | 9.82M | 7.91M | 7.91M | 7.45M | 7.92M | 8.99M | 11.36M | 11.75M |
| Other Non-Cash Items | -22.86M | -36.31M | -22.16M | 1.61M | 32.2M | 217.8M | 98.55M | 27.77M | 4.6M | 4.68M |
| Working Capital Changes | -90.31M | -18.5M | -23.51M | -2.74M | 22.7M | -19.69M | -2.73M | -22.55M | -9.85M | -2.33M |
| Cash from Investing | -240.07M | -258.49M | 262.84M | -136.45M | -336.2M | -216.25M | 103.13M | -109M | -377.96M | -466.61M |
| Acquisitions (Net) | 77.86M | -354.46M | 0 | -16.65M | -7.77M | -142.91M | -5.24M | 0 | 0 | 1.98M |
| Purchase of Investments | -2.75M | -5.31M | -89.65M | -20.07M | -9.06M | -8.02M | -11.02M | 0 | 0 | 0 |
| Sale of Investments | 3.75M | 6.87M | 5.08M | 3.42M | 1.29M | 5.38M | 0 | 0 | 0 | -1.37M |
| Other Investing | 15.19M | 1.06M | 347.42M | 2.44M | -287.05M | -70.69M | 119.39M | -109M | -377.96M | -467.21M |
| Cash from Financing | 598.82M | -629.34M | -646.18M | -202.11M | 30.14M | -161.71M | -410.3M | -181.56M | 40.76M | 194.1M |
| Dividends Paid | -182.09M | -325.22M | -335.44M | -278.3M | -262.92M | -277.16M | -277.45M | -280.15M | -289.5M | -293.78M |
| Common Dividends | -182.09M | -325.22M | -335.44M | -278.3M | -262.92M | -277.16M | -277.45M | -280.15M | -289.5M | -218.12M |
| Debt Issuance (Net) | 1000K | -1000K | -1000K | -1000K | 1000K | 1000K | -1000K | 1000K | 1000K | 1000K |
| Share Repurchases | 0 | -143.75M | 0 | 0 | 0 | -4.81M | -2.68M | 0 | 0 | 0 |
| Other Financing | -15.75M | -2.54M | -10.82M | -830K | -39.51M | -2.52M | -36.04M | -94K | -5.24M | 122.59M |
| Net Change in Cash | 492.97M▲ 0% | -527.79M▼ 207.1% | -10.52M▲ 98.0% | 16.38M▲ 255.8% | 50.36M▲ 207.5% | -61.95M▼ 223.0% | -7.21M▲ 88.4% | 19.62M▲ 372.0% | 11.8M▼ 39.9% | 94.55M▲ 0% |
| Exchange Rate Effect | 738K | -539K | 346K | 88K | 29K | 268K | -614K | -359K | 391K | 410K |
| Cash at Beginning | 25.66M | 587.45M | 59.66M | 49.14M | 65.52M | 115.89M | 53.93M | 46.72M | 66.34M | 78.14M |
| Cash at End | 518.63M | 59.66M | 49.14M | 65.52M | 115.89M | 53.93M | 46.72M | 66.34M | 78.14M | 123.45M |
| Free Cash Flow | -200.64M▲ 0% | 451.89M▲ 325.2% | 372.48M▼ 17.6% | 249.26M▼ 33.1% | 322.78M▲ 29.5% | 315.73M▼ 2.2% | 300.57M▼ 4.8% | 310.54M▲ 3.3% | 348.61M▲ 12.3% | 366.71M▲ 0% |
| FCF Growth % | -213.52% | 325.22% | -17.57% | -33.08% | 29.5% | -2.18% | -4.8% | 3.32% | 12.26% | 8.49% |
| FCF / Revenue % | -49.46% | 72.49% | 55.74% | 41.64% | 56.67% | 50.53% | 46.42% | 44.16% | 45% | 45.11% |
Sabra Health Care REIT, Inc. (SBRA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| FFO per Share | 3.04 | 3.27 | 1.33 | 1.52 | 0.3 | 0.48 | 0.85 | 1.26 | 1.4 | 1.38 |
| FFO Payout Ratio | 56.58% | 55.57% | 134.15% | 88.31% | 399.97% | 251.56% | 140.95% | 94.54% | 84.5% | 61.82% |
| NOI Margin | 95.6% | 92.05% | 83.58% | 78.02% | 75.21% | 73.97% | 69.85% | 67.71% | 65% | 63.48% |
| Net Debt / EBITDA | 7.42x | 5.19x | 3.43x | 5.68x | 5.98x | 5.91x | 5.94x | 5.59x | 5.50x | 5.50x |
| Debt / Assets | 48.27% | 48.49% | 40.89% | 40.6% | 40.96% | 44.35% | 45.42% | 46.09% | 46.42% | 22.47% |
| Interest Coverage | 2.80x | 2.92x | 2.73x | 2.39x | -0.13x | 0.28x | 1.14x | 2.11x | 2.40x | - |
| Book Value / Share | 32.48 | 18.21 | 18.54 | 16.45 | 15.43 | 13.23 | 12.04 | 11.61 | 11.55 | 10.89 |
| Revenue Growth | 55.7% | 53.68% | 7.18% | -10.42% | -4.85% | 9.7% | 3.63% | 8.61% | 10.15% | 12.89% |
Sabra Health Care REIT, Inc. (SBRA) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 29, 2026·SEC
Feb 12, 2026·SEC
Jan 5, 2026·SEC
Sabra Health Care REIT, Inc. (SBRA) stock FAQ — growth, dividends, profitability & financials explained
Sabra Health Care REIT, Inc. (SBRA) reported $812.8M in revenue for fiscal year 2025. This represents a 9137% increase from $8.8M in 2010.
Sabra Health Care REIT, Inc. (SBRA) grew revenue by 10.2% over the past year. This is steady growth.
Yes, Sabra Health Care REIT, Inc. (SBRA) is profitable, generating $156.2M in net income for fiscal year 2025 (20.1% net margin).
Yes, Sabra Health Care REIT, Inc. (SBRA) pays a dividend with a yield of 5.81%. This makes it attractive for income-focused investors.
Sabra Health Care REIT, Inc. (SBRA) has a return on equity (ROE) of 5.6%. This is below average, suggesting room for improvement.
Sabra Health Care REIT, Inc. (SBRA) generated Funds From Operations (FFO) of $352.8M in the trailing twelve months. FFO is the primary profitability metric for REITs.
Sabra Health Care REIT, Inc. (SBRA) offers a 5.81% dividend yield, which is attractive for income investors. REITs are required to distribute at least 90% of taxable income to shareholders.
Sabra Health Care REIT, Inc. (SBRA) financial analysis — history, returns, DCA and operating performance tools
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates